Stocks · Healthcare · Biotechnology
Equillium, Inc. EQ
$1.41 -8.44% Close, Oct 2, 2026 · NASDAQ · Market cap $89.1M
Expensive vs sector
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 213.0% in a year.
- The stock is 56% below its highest close of the past year.
- The company holds net cash of $56.6M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 2%
- Revenue growth accelerationTop 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 39%
- Accruals (lower is better)Bottom 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 36%
- Free-cash-flow yieldBottom 23%
- EBITDA / enterprise valueBottom 10%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 32%
- 6-month returnBottom 18%
- 1-year return vs S&P 500Bottom 40%
- Distance from 52-week highBottom 16%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 24%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 24%
- Upside to consensus price targetTop 8%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 19%
- Maximum drawdown, 3 yearsBottom 15%
- Beta vs S&P 500 (lower is better)Top 1%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -100.0% | -100.0% | → |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -100.0% | -100.0% | → | Bottom 2% |
| Return on invested capital | -34.1% | — | Bottom 39% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 3.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -73.74%
- Shareholder yield
- -73.74%
- Share count change, 1 year
- +213.0%
- Share count change, 3-year CAGR
- +48.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +19.0%
- Average 2-day reaction, last 8
- -6.3%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $6.25
- Target vs current price
- +343.3%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 92%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +25.9% | -7.8% | +6.9% | +11.0% | — |
| May 13, 2026 | -50.0% | +1.8% | -22.0% | +17.6% | -7.0% |
| Mar 25, 2026 | +42.9% | +5.6% | +2.6% | +19.5% | +56.4% |
| Nov 13, 2025 | +57.1% | -9.1% | +9.3% | +45.0% | +64.5% |
| Aug 14, 2025 | -14.3% | +5.4% | +22.6% | +114.0% | +35.5% |
| May 14, 2025 | -4.3% | -2.3% | +0.8% | +1.0% | +29.6% |
| Mar 27, 2025 | +27.3% | -35.6% | -35.2% | -38.0% | -61.7% |
| Nov 13, 2024 | +99.9% | -8.2% | -17.6% | -17.3% | +4.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.04 | -$0.05 | +25.9% | — |
| May 13, 2026 | -$0.06 | -$0.04 | -50.0% | — |
| Mar 25, 2026 | -$0.04 | -$0.07 | +42.9% | — |
| Nov 13, 2025 | -$0.06 | -$0.14 | +57.1% | — |
| Aug 14, 2025 | -$0.16 | -$0.14 | -14.3% | — |
| May 14, 2025 | -$0.24 | -$0.23 | -4.3% | — |
| Mar 27, 2025 | -$0.16 | -$0.22 | +27.3% | $4.4M |
| Nov 13, 2024 | -$0.00 | -$0.26 | +99.9% | $12.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -22.54% | — | — | Bottom 23% |
| Earnings yield | -18.18% | — | — | Bottom 36% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -14.7%
- 200-day average slope (20 days)
- +4.7%
- Distance from 50-day average
- -33.8%
- Distance from 200-day average
- -32.0%
- RSI (14)
- 25.1
- Relative volume
- 1.31×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 79.2%
- Volatility vs own 5-year history
- 24th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.43
- Correlation with S&P 500
- -0.04
- Current drawdown from 1-year high
- -55.9%
- Maximum drawdown, 3 years
- -90.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 12, 2021 | Jun 23, 2025 | -97.2% | 1093 days | Not yet recovered |
| Oct 7, 2020 | Nov 10, 2020 | -47.1% | 24 days | 50 days (Jan 25, 2021) |
| Jan 25, 2021 | Jan 29, 2021 | -15.7% | 4 days | 4 days (Feb 4, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $89.1M
- EPS, diluted (TTM)
- -$0.26
- Revenue (TTM)
- $0
- 52-week range
- $0.76 – $3.54
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $15.8M | $36.1M | $41.1M | $0 |
| Gross profit | $0 | $15.8M | $36.1M | $41.1M | -$116,000 |
| Operating income | -$37.8M | -$62.1M | -$14.5M | -$8.3M | -$23.6M |
| Net income | -$39.0M | -$62.4M | -$13.3M | -$8.1M | -$22.4M |
| EPS (diluted) | -$1.35 | -$3.19 | -$0.38 | -$0.23 | -$0.39 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2M | $4.4M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$7,000 | -$5.8M | -$8.7M | -$5.7M | -$4.2M | -$3.8M | -$5.3M | -$4.7M |
| EPS (diluted) | -$0.00 | -$0.16 | -$0.24 | -$0.16 | -$0.12 | -$0.04 | -$0.06 | -$0.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$32.1M | -$8.7M | -$21.8M | -$19.0M | -$22.7M |
| Capital expenditure | -$57,000 | -$279,000 | -$50,000 | -$85,000 | -$48,000 |
| Free cash flow | -$32.1M | -$9.0M | -$21.8M | -$19.1M | -$22.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $29.9M | $214,000 | -$260,000 | $164,000 | $30.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $57.2M
- Total assets
- $58.7M
- Total liabilities
- $2.6M
- Total debt
- $584,000
- Net debt
- -$56.6M
- Shareholders’ equity
- $56.0M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 5,500,539
- Days to cover
- 15.03
- Change vs previous report
- +2.4%
FINRA short interest, settlement date Sep 15, 2026.